![]() |
市場調查報告書
商品編碼
1696250
全球 Omega-3 市場 - 2025 至 2032 年Global Omega-3 Market - 2025-2032 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2024 年全球 Omega-3 市場規模達到 26.4 億美元,預計到 2032 年將達到 48.5 億美元,在 2025-2032 年預測期內的複合年成長率為 7.92%。
市場擴張是由於人類飲食中擴大使用 omega-3 成分來增強大腦和心臟健康。此外,預計醫療保健和個人健康方面的消費者支出增加將推動產品需求。隨著消費者尋求傳統魚油的替代品,市場不斷實現產品來源多樣化。磷蝦油是最廣泛使用的 Omega-3 來源之一,因為與普通魚油相比,它具有更優良的品質。
此外,Aker Biomarine Antarctic AS 等重要企業正致力於透過引進新的捕撈船來增加其產品供應,以提高產能,該公司 2021 年的收入就是明證。發展中國家的政府正在推出多項措施來鼓勵南極磷蝦捕撈,包括提供研究資金和組成創新聯盟,這可能會刺激產業成長。預計這些變數將在預測期內推動產品需求。
動態的
Omega-3 的健康益處日益增加
人類飲食中需要含有 Omega-3 脂肪酸,尤其是 EPA 和 DHA,以確保適當的生長、發育和健康。它們有益於心臟健康、關節和發炎緩解、眼睛健康、認知功能、懷孕和兒童發育以及免疫功能。眾所周知,Omega-3 脂肪酸可以降低心血管疾病的風險。近年來,全球心血管疾病死亡率呈上升趨勢。在西撒哈拉以南非洲和南亞,心血管疾病發生率上升。根據聯合國人口基金會(印度)的數據,到 2050 年,印度老年人罹患心臟病的數量預計將達到 1,910 萬人。
印度和中國等國家心臟病發病率不斷上升,對心臟保健產品的需求不斷增加,從而促進了 omega-3 產品市場的發展。 Omega-3 脂肪酸還可以幫助預防和治療多種眼部問題,包括乾眼症。根據研究,攝取 omega-3 脂肪酸(無論是透過膳食或補充劑)都可能降低黃斑部病變和青光眼的幾率。因此,預計 omega-3 對人類健康不同方面的益處將推動其市場需求。
供應鏈約束和永續性挑戰
全球 Omega-3 市場的主要限制因素之一是由於過度捕撈和環境法規導致的魚油原料稀缺。大部分 omega-3 產品來自海洋資源,包括鯷魚、沙丁魚和鯖魚,這些資源受季節變化、地緣政治限制和永續性需求的影響。
例如,2023年,全球最大的鳳尾魚油生產國秘魯因魚類數量減少而實施捕撈禁令,導致 Omega-3 市場供應短缺和價格不穩定。因此,製造商現在正在尋找替代來源,例如藻類衍生的 omega-3,儘管這些來源仍然更昂貴且需要更高的可擴展性才能滿足不斷成長的全球需求。
Global Omega-3 Market reached US$ 2.64 billion in 2024 and is expected to reach US$ 4.85 billion by 2032, growing with a CAGR of 7.92% during the forecast period 2025-2032.
The market expansion is due to the increasing use of omega-3 ingredients in the human diet to enhance brain and heart health. Furthermore, rising consumer spending in healthcare and personal well-being is predicted to drive product demand. The market is constantly diversifying its product sources as consumers seek alternatives to traditional fish oil. Krill oil is one of the most extensively used sources of omega-3 because of its superior qualities when compared to regular fish oil.
Furthermore, significant enterprises like as Aker Biomarine Antarctic AS are working on boosting capacity by introducing new catching vessels to increase their product offerings, as evidenced by the company's revenues in 2021. Governments in developing countries are launching a number of initiatives to encourage Antarctic Krill fishing, including providing research money and forming innovative alliances, which could spur industry growth. Such variables are expected to drive the product demand during the forecast period.
Dynamic
Rising Health Benefits of Omega-3
Omega-3s, notably EPA and DHA, are required in the human diet for appropriate growth, development and health. They are beneficial for heart health, joint and inflammation relief, eye health, cognitive function, pregnancy and child development and immune function. Omega-3 fatty acids are recognized to lessen the risk of cardiovascular disease. Cardiovascular disease mortality has recently been on the rise around the world. In Western Sub-Saharan Africa and South Asia, cardiovascular disease rates have risen. According to the United Nations Population Fund (India), the number of instances of heart disease among older adults in India is anticipated to be 19.1 million by 2050.
Countries such as India and China, where the prevalence of heart disease is expanding, create demand for heart health goods, bolstering the omega-3 product market. Omega-3 fatty acids can also help prevent and treat several eye problems, including dry eye syndrome. According to studies, ingesting omega-3 fatty acids, whether in meals or supplements, may lower your chance of getting macular degeneration and glaucoma. As a result, omega-3's benefits in different aspects of human health are projected to boost its market demand.
Supply Chain Constraints and Sustainability Challenges
One of the primary constraints in the global omega-3 market is the scarcity of fish oil-based raw materials due to overfishing issues and environmental regulations. The majority of omega-3 production comes from marine sources including anchovies, sardines and mackerel, which are subject to seasonal changes, geopolitical constraints and sustainability demands.
For example, in 2023, Peru, the world's top producer of anchovy-based fish oil, implemented fishing prohibitions owing to diminishing fish populations, resulting in supply shortages and price instability in the omega-3 market. As a result, manufacturers are now searching for alternate sources like algae-derived omega-3, although these are still more expensive and require more scalability to satisfy expanding worldwide demand.
The global omega-3 market is segmented based on source, type, application and region.
DHA in the global market is expected to drive the market.
In 2024, the DHA segment accounted for the largest percentage of global omega-3 market. The segment's growth is due to the increasing use of the product in newborn formulae to improve an infant's overall health. DHA is the most vital and plentiful omega-3 fatty acid in the human diet, contributing to overall body health. DHA is essential for the development and maturation of an infant's brain and vision.
Furthermore, it is commonly utilized in dietary supplements and fortified foods. It is used to treat dementia, ADHD, CAD and type 2 diabetes. Companies create new items to fulfill market demand. For example, in 2022 orlo Nutrition launched a DHA Starter Kit with an algal omega-3 supplement to assist the brain, heart, joints and body systems.
Growing Health Consciousness in Asia-Pacific.
Asia-Pacific is expected to be the fastest growing region in the global omega-3 market. Several reasons fueling the region's growth include expanding consumer health consciousness, an aging population valuing cognitive health and high birth rates, which increase demand for infant nutritional products. Additionally, the popularity of plant-based diets has resulted in an increase in demand for algae-based omega-3 supplements.
Furthermore, other significant players have innovated, such as Daewoong Bio, which developed CRA-TG in June 2024, a combination of the hyperlipidemia medicine rosuvastatin and omega-3 intended at lowering patients' triglyceride levels. This new addition to Daewoong Bio's hyperlipidemia treatment range joins nine other medications, including Atorvastatin Tablets and Oma-TG Soft Capsule. CRA-TG has exhibited better lipid profiles and increased tolerance and stability.
The major global players in the market include Polaris, Koninklijke DSM N.V., BASF SE, Corbion NV, ADM, Simris Alg AB, Croda International Plc, Novotech Nutraceuticals, Inc., Source Omega LLC and Algarithm.
Target Audience 2024
LIST NOT EXHAUSTIVE